Isotretinoin
![[Docket No. FDA-2020-N-1058] Keith Komar](http://data.docslib.org/img/264x/1f429b1684683d0814109defaa0bf454.webp)
Top View
- Management of Acne
- Patients' Perceptions of Isotretinoin, Depression and Suicide
- Acne Relapses and Maintenance Therapy
- Tazarotene Cream for the Treatment of Facial
- Long-Term Results of Isotretinoin in the Treatment of 68 Patients with Hidradenitis Suppurativa
- ACCUTANE (Isotretinoin Capsules)
- BICALUTAMIDE -- Withdrawn Due to Accelerated Deaths
- Acne Prescribing Guidelines - Clinical Management in Primary Care
- Tazarotene Cream for Postinflammatory Hyperpigmentation and Acne Vulgaris in Darker Skin: a Double-Blind, Randomized, Vehicle-Controlled Study
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- Anti-Androgen Therapy in Female Adult Acne Jing Gao* and Anjali Mahto Check for Department of Dermatology, Northwick Park Hospital, London, United Kingdom Updates
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Therapeutic Class Overview Benzoyl Peroxide/Antibiotic Combinations
- Summary of Product Characteristics, Labelling and Package Leaflet
- List Item Isotretinoin
- The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
- Comparison of the Therapeutic Efficacy of Erythromycin and Low Dose Isotretinoin by Erythromycin and Low Dose Flutamide for Women with Severe Acne
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name